Brainstorm Cell Therapeutics Inc. (BCLI)
Depreciation & Amortization
$179.00K
TTM · Period ending: · USD
BCLI Depreciation & Amortization
Latest reported$179.00Kperiod ending
Latest reported$179.00Kperiod ending
BCLI TTM Depreciation & Amortization ($17.40K → $179.00K)
TTM Depreciation & Amortization
High-resolution chart · PNG
BCLI depreciation & amortization history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 179,000 | |
| 184,000 | |
| 199,000 | |
| 204,000 | |
| 215,000 | |
| 228,000 | |
| 240,000 | |
| 253,000 | |
| 259,000 | |
| 262,000 | |
| 265,000 | |
| 269,000 | |
| 274,000 | |
| 278,000 | |
| 285,000 | |
| 285,000 | |
| 282,000 | |
| 273,000 | |
| 260,000 | |
| 254,000 | |
| 243,000 | |
| 231,000 | |
| 219,000 | |
| 205,000 | |
| 186,000 | |
| 169,000 | |
| 164,000 | |
| 135,000 | |
| 131,000 | |
| 129,000 | |
| 110,000 | |
| 117,000 | |
| 107,000 | |
| 94,000 | |
| 85,000 | |
| 79,000 | |
| 73,000 | |
| 77,000 | |
| 77,000 | |
| 69,000 | |
| 78,000 | |
| 80,000 | |
| 87,000 | |
| 99,000 | |
| 103,000 | |
| 104,000 | |
| 106,000 | |
| 80,000 | |
| 77,000 | |
| 69,000 | |
| 77,000 | |
| 196,000 | |
| 208,000 | |
| 191,000 | |
| 196,000 | |
| 114,000 | |
| 115,000 | |
| 153,000 | |
| 153,000 | |
| 116,000 | |
| 118,000 | |
| 80,000 | |
| 42,000 | |
| 42,000 | |
| 0 | |
| 0 | |
| 0 | |
| 812,000 | |
| 461,000 | |
| 657,000 | |
| 925,000 | |
| -1,554,000 | |
| -562,000 | |
| -266,902 | |
| 99,000 | |
| 1,129,579 | |
| 956,017 | |
| 873,481 | |
| 648,141 | |
| 2,134,143 | |
| 2,055,889 | |
| 1,868,655 | |
| 1,767,970 | |
| 918,389 | |
| 529,205 | |
| 307,877 | |
| 6,314 | |
| 12,243 | |
| 18,172 | |
| 23,714 | |
| 17,400 | |
| 27,985 | |
| 30,306 | |
| 30,514 |